AUTHOR=Song Yongyan , Li Shujin , He Chuan 

TITLE=PPARγ Gene Polymorphisms, Metabolic Disorders, and Coronary Artery Disease

JOURNAL=Frontiers in Cardiovascular Medicine

VOLUME=9

YEAR=2022

URL=https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.808929

DOI=10.3389/fcvm.2022.808929

ISSN=2297-055X

ABSTRACT=<p>Being activated by endogenous and exogenous ligands, nuclear receptor peroxisome proliferator-activated receptor gamma (PPARγ) enhances insulin sensitivity, promotes adipocyte differentiation, stimulates adipogenesis, and has the properties of anti-atherosclerosis, anti-inflammation, and anti-oxidation. The Human PPARγ gene (<italic>PPARG</italic>) contains thousands of polymorphic loci, among them two polymorphisms (rs10865710 and rs7649970) in the promoter region and two polymorphisms (rs1801282 and rs3856806) in the exonic region were widely reported to be significantly associated with coronary artery disease (CAD). Mechanistically, <italic>PPARG</italic> polymorphisms lead to abnormal expression of <italic>PPARG</italic> gene and/or dysfunction of PPARγ protein, causing metabolic disorders such as hypercholesterolemia and hypertriglyceridemia, and thereby increasing susceptibility to CAD.</p>